Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 8


GTI: a novel algorithm for identifying outlier gene expression profiles from integrated microarray datasets.

Mpindi JP, Sara H, Haapa-Paananen S, Kilpinen S, Pisto T, Bucher E, Ojala K, Iljin K, Vainio P, Björkman M, Gupta S, Kohonen P, Nees M, Kallioniemi O.

PLoS One. 2011 Feb 18;6(2):e17259. doi: 10.1371/journal.pone.0017259. Erratum in: PLoS One. 2011;6(4). doi:10.1371/annotation/7d571883-faf0-4f66-86a2-806c36c4741c.


FZD4 as a mediator of ERG oncogene-induced WNT signaling and epithelial-to-mesenchymal transition in human prostate cancer cells.

Gupta S, Iljin K, Sara H, Mpindi JP, Mirtti T, Vainio P, Rantala J, Alanen K, Nees M, Kallioniemi O.

Cancer Res. 2010 Sep 1;70(17):6735-45. doi: 10.1158/0008-5472.CAN-10-0244. Epub 2010 Aug 16.


Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis.

Pollari S, Käkönen SM, Edgren H, Wolf M, Kohonen P, Sara H, Guise T, Nees M, Kallioniemi O.

Breast Cancer Res Treat. 2011 Jan;125(2):421-30. doi: 10.1007/s10549-010-0848-5. Epub 2010 Mar 30. Erratum in: Breast Cancer Res Treat. 2012 Feb;131(3):1085-6.


A decade of cancer gene profiling: from molecular portraits to molecular function.

Sara H, Kallioniemi O, Nees M.

Methods Mol Biol. 2010;576:61-87. doi: 10.1007/978-1-59745-545-9_5. Review.


Mammary-derived growth inhibitor alters traffic of EGFR and induces a novel form of cetuximab resistance.

Nevo J, Mattila E, Pellinen T, Yamamoto DL, Sara H, Iljin K, Kallioniemi O, Bono P, Heikkilä P, Joensuu H, Wärri A, Ivaska J.

Clin Cancer Res. 2009 Nov 1;15(21):6570-81. doi: 10.1158/1078-0432.CCR-09-0773. Epub 2009 Oct 13.


Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissues.

Kilpinen S, Autio R, Ojala K, Iljin K, Bucher E, Sara H, Pisto T, Saarela M, Skotheim RI, Björkman M, Mpindi JP, Haapa-Paananen S, Vainio P, Edgren H, Wolf M, Astola J, Nees M, Hautaniemi S, Kallioniemi O.

Genome Biol. 2008;9(9):R139. doi: 10.1186/gb-2008-9-9-r139. Epub 2008 Sep 19.


Defining the molecular action of HDAC inhibitors and synergism with androgen deprivation in ERG-positive prostate cancer.

Björkman M, Iljin K, Halonen P, Sara H, Kaivanto E, Nees M, Kallioniemi OP.

Int J Cancer. 2008 Dec 15;123(12):2774-81. doi: 10.1002/ijc.23885.


Role of ErbB4 in breast cancer.

Sundvall M, Iljin K, Kilpinen S, Sara H, Kallioniemi OP, Elenius K.

J Mammary Gland Biol Neoplasia. 2008 Jun;13(2):259-68. doi: 10.1007/s10911-008-9079-3. Epub 2008 May 3. Review.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk